Pharmaceutical Green Chemistry process changes-how long does it take to obtain regulatory approval?

Green Chemistry

Volumn 15, Issue 11, 2013, Pages 3099-3104

  Dunn, Peter J ^a  

^a PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84886377016     PISSN: 14639262     EISSN: 14639270     Source Type: Journal    
DOI: 10.1039/c3gc41376d     Document Type: Article

References (24)

1. Green Chemistry in the Pharmaceutical Industry, ed., P. J. Dunn, A. S. Wells, and, M. T. Williams, Wiley-VCH, 2010
2. P. J. Dunn Chem. Soc. Rev. 2012 41 1452 1461
3. W. J. W. Watson Green Chem. 2012 14 251 259
4. The ACS GCI Pharmaceutical Roundtable is a group of 16 companies who promote Green Chemistry and Engineering in the Pharmaceutical Industry for further information see the following link. http://portal.acs.org/portal/acs/ corg/content?-nfpb=true&-pageLabel=PP-TRANSITIONMAIN&node-id= 1422&use-sec=false&sec-url-var=region1&-uuid=36e39cf8-01d2-4686- 8424-8d10fdbb2565
5. M. S. Hoekstra D. M. Sobiery M. A. Schwindt T. A. Mulhern T. M. Grote B. K. Huckabee V. S. Hendrickson L. C. Franklin E. J. Granger G. L. Karrick Org. Process Res. Dev. 1997 1 26 38
6. R. A. Sheldon Chem. Ind. 1992 903 906
7. R. A. Sheldon Green Chem. 2007 9 1273 1283
8. G. Hoge H.-P. Wu W. S. Kissel D. A. Pflum D. J. Greene J. Bao J. Am. Chem. Soc. 2004 126 5966 5967
9. M. J. Burk P. D. de Koning T. M. Grote M. S. Hoekstra G. Hoge R. A. Jennings W. S. Kissel T. V. Le I. C. Lennon T. A. Mulhern J. A. Ramsden R. A. Wade J. Org. Chem. 2003 68 5731 5734
10. C. A. Martinez S. Hu Y. Dumond J. Tao P. Kelleher L. Tully Org. Process Res. Dev. 2008 12 392 398
11. P. J. Dunn, K. Hettenbach, P. Kelleher and C. A. Martinez, The Development of a Green, Energy Efficient, Chemoenzymatic Manufacturing Process for Pregabalin, in Green Chemistry in the Pharmaceutical Industry, ed., P. J. Dunn, A. S. Wells, and, M. T. Williams, Wiley-VCH, 2010, pp. 161-178
12. M. Savelski, C. S. Slater, P. Dunn, D. Knochel and C. Visnic, "Use of Life Cycle Assessment to Evaluate the Sustainable Manufacture of the Active Pharmaceutical Ingredient Pregabalin", AIChE Annual Meeting, Minneapolis, October 2011. Paper 124c. The life cycle and carbon footprint results presented in Figure 1 were based on a collaboration between Rowan University and Pfizer
13. F. W. Reimherr W. F. Byerley M. F. Ward B. J. Lebegue P. H. Wender Psychopharmacol. Bull. 1988 24 200 205
14. G. J. Quallich Chirality 2005 17 S120 S126
15. A. P. Guy, US Patent, 5,019,655, 1991
16. J. C. Colberg, D. Pfisterer and G. P. Taber, US Patent, 6,232,500, 2001
17. G. P. Taber D. M. Pfisterer J. C. Colberg Org. Process Res. Dev. 2004 8 385 388
18. For further information and details of waste savings see US Presidential Green Chemistry Challenge Awards, Green Synthetic Pathways Award 2002 http://www.epa.gov/greenchemistry/pubs/pgcc/past.html#2002
19. P. Duriez Expert Opin. Pharmacother. 2001 2 1777 1794
20. P. L. Browner D. E. Butler C. F. Deering T. V. Le A. Millar T. N. Nanninga B. D. Roth Tetrahedron Lett. 1992 33 2279 2282
21. K.-M. Chen G. E. Hardman K. Prasad O. Repic M. J. Shapiro Tetrahedron Lett. 1987 28 155 158
22. J. J. Li, D. S. Johnson, D. R. Sliskovic and B. D. Roth, Contemporary Drug Synthesis, Wiley-Interscience, 2004, pp. 113-124
23. th ACS Mid Atlantic Regional Meeting, 17-21 May, Bayside, New York, 2008
24. B. W. Cue J. Zhang Green Chem. Lett. Rev. 2009 2 193 211